# Kite Pharma, Inc. – FDA Inspection, Nov 1, 2024

Source: https://www.keypedia.com/records/fda_inspections/kite-pharma-inc/1356c91e-dcb6-455b-869d-a58969e2a431
Source feed: FDA_Inspections

> FDA inspection 1253766 of Kite Pharma, Inc., November 01, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 600. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1253766
- Company Name: Kite Pharma, Inc.
- Inspection Date: 2024-11-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Baltimore District Office
- Citation Count: 1

## Related Officers

- [FDA Personnel](https://www.keypedia.com/people/lizaida-perez/686fbdca-bfd7-4a73-990a-d8a97e6b88b7)
- [Investigator](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)
- [Issuing Officer](https://www.keypedia.com/people/richard-l-bartlett/602337b9-ac77-41bb-a254-71a9d345335b)

Company: https://www.keypedia.com/companies/kite-pharma-inc/3b951fdd-ddaa-4306-bff9-aee14a93c6d5

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
